ArticleCancers2025

Dose-Escalated SBRT for Borderline and Locally Advanced Pancreatic Cancer: Resectability Rate and Pathological Results of a Multicenter Prospective Study.

Barbara Salas-Salas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.